BioCentury
ARTICLE | Clinical News

Equasym XL methylphenidate extended-release capsules regulatory update

May 29, 2006 7:00 AM UTC

UCB completed the European Mutual Recognition Procedure (MRP) for Equasym XL to treat symptoms of attention deficit hyperactivity disorder (ADHD). The U.K. acted as the reference member state. The com...